Astrazeneca Pharma India (ASTRAZEN) Share Price hits fresh 52-week low; stock trades at Rs 6020.3
- September 1, 2026
- Posted by: Kunal Singla
- Category: News
Astrazeneca Pharma India Share Price drew attention in morning trade on 05 October 2026 at 9:22 AM IST after the stock touched a fresh 52-week low of Rs 5,942.3 and last traded at Rs 6,020.3, down Rs 10.15 or 0.17%. The company’s market capitalisation stood at Rs 15,076.13 crore. The price move is confirmed in Univest data; a company-specific reason has not been established. For Astrazeneca Pharma India Share Price, the key point is not only the intraday low but also the distance between the last traded price, the day’s open of Rs 6,078.15 and the low of Rs 5,942.3. In Univest’s view, that makes Astrazeneca Pharma India Share Price relevant for readers tracking stock performance, valuation and healthcare sector comparison.
Astrazeneca Pharma India Share Price also matters because the stock is trading near the lower end of its day’s range while the company remains in the Healthcare sector and the Pharmaceuticals & Drugs industry. The latest Univest figures show a high valuation profile versus the broader industry, so Astrazeneca Pharma India Share Price is best read through both price action and fundamentals. The next sections explain what happened today, how Astrazeneca Pharma India Share Price compares with peers, and why investors are watching the yearly low move.
Astrazeneca Pharma India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 6,020.3 |
| Previous Close | Rs 6,030.45 |
| Today's Move | Rs -10.15 (-0.17%) |
| Open | Rs 6,078.15 |
| High | Rs 6,078.15 |
| Low | Rs 5,942.3 |
| Market Capitalisation | Rs 15,076.13 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 6,020.3 versus the previous close of Rs 6,030.45, a fall of 0.17%. The stock opened at Rs 6,078.15, reached a high of Rs 6,078.15, touched a low of Rs 5,942.3.
Astrazeneca Pharma India Share Price traded at Rs 6,020.3 against a previous close of Rs 6,030.45, with a day change of Rs -10.15 and a day change percentage of -0.17%. The stock opened at Rs 6,078.15, touched a high of Rs 6,078.15 and a low of Rs 5,942.3, which is also the fresh 52-week low. As of 05 October 2026 at 9:22 AM IST, Astrazeneca Pharma India Share Price was therefore moving inside a narrow early range before easing to the yearly low. The latest Univest figures show that the market capitalisation remained Rs 15,076.13 crore even as the price set a new one-year low. For readers tracking Astrazeneca Pharma India Share Price Today, the verified facts are straightforward: a fresh 52-week trough, a small negative move and an intraday low that matched the 52-week low.
What exactly happened today is that Astrazeneca Pharma India Share Price touched Rs 5,942.3 in the morning session and then last traded above that point at Rs 6,020.3. According to latest Univest figures, the event is a fresh 52-week low rather than an all-time low. That distinction matters for Astrazeneca Pharma India Share Price because the current move should be read as a yearly low event, not a lifetime low event. The price action now leads into the more important question for Astrazeneca Pharma India Share Price: whether valuation and company financials justify close monitoring at this level.
Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 15,076.13 crore |
| P/E Ratio | 88.88x |
| P/B Ratio | 16.67x |
| ROE | 23.02% |
| ROCE | 31.24% |
| EPS | Rs 67.85 |
| Book Value Per Share | Rs 361.68 |
| Dividend Yield | 0.6% |
Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P/E 88.88x, P/B 16.67x, ROE 23.02%, ROCE 31.24%. These ratios show where the company stands today and are not a call to buy or sell.
Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 15,076.13 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 88.88x, P/B at 16.67x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.6%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.94x, median ROE of 11.43%, median ROCE of 13.1%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 88.88x |
| Benchmark Median P/E | 31.94x |
| Benchmark Average P/E | 48.43x |
| Benchmark P/E Range | 3.58x to 685.2x |
| Company P/B Ratio | 16.67x |
| Benchmark Median P/B | 2.84x |
| Company ROE | 23.02% |
| Benchmark Median ROE | 11.43% |
| Company ROCE | 31.24% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 15,076.13 crore |
| Benchmark Median Market Cap | Rs 695.84 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 88.88x, which is above the benchmark median of 31.94x, a difference of +178.27%. A P/E difference of this kind is a reference point rather than a recommendation.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.43%, a difference of +101.4%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.1%, a difference of +138.47%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Marksans Pharma Ltd. | MARKSANS | 14,736.89 | 28.52 | 4.64 | 15.31 | 21.1 |
| Concord Biotech Ltd. | CONCORDBIO | 14,385.25 | 52.24 | 6.94 | 13.54 | 18.04 |
| Jubilant Pharmova Ltd. | JUBLPHARMA | 15,938.47 | 45.27 | 2.24 | 5.97 | 8.69 |
| Alembic Pharmaceuticals Ltd. | APLLTD | 16,019.89 | 23.1 | 2.74 | 12.35 | 11.74 |
| Natco Pharma Ltd. | NATCOPHARM | 16,120.1 | 14.09 | 1.72 | 16.3 | 17.16 |
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 88.88x compared with the displayed peer median of 28.52x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.02% compares with a peer median of 13.54% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 17.16%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 15,076.13 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Astrazeneca Pharma India Share Price
- Astrazeneca Pharma India Share Price touched a fresh 52-week low of Rs 5,942.3 while trading at Rs 6,020.3 in morning trade.
- The market capitalisation of Rs 15,076.13 crore keeps Astrazeneca Pharma India Share Price in focus among Healthcare names.
- P/E of 88.88 and P/B of 16.67 place Astrazeneca Pharma India Share Price at a premium versus the industry benchmark.
- ROE of 23.02% and ROCE of 31.24% keep Astrazeneca Pharma India Share Price relevant in fundamental analysis.
- The Jun 2026 revenue figure of Rs 682.79 crore adds a current operating reference for Astrazeneca Pharma India Share Price.
About Astrazeneca Pharma India
Astrazeneca Pharma India Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. Astrazeneca Pharma India Share Price reflects a business that is best understood through its operating profile, valuation and return ratios rather than through a single day’s move. The company’s market capitalisation of Rs 15,076.13 crore places it among established listed healthcare names in the selected peer group.
For readers tracking Astrazeneca Pharma India Share Price, the key business context is that the company belongs to a sector where valuation, research-led products and profitability measures tend to matter together. Jun 2026 revenue of Rs 682.79 crore provides the latest revenue reference in Univest data. Astrazeneca Pharma India Share Price therefore sits at the intersection of business performance, healthcare sector positioning and premium valuation, which is why its stock news is being followed closely today.
Track Astrazeneca Pharma India Share Price on Univest
Use Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Readers can track Astrazeneca Pharma India Share Price on Univest for live price updates, valuation ratios, 52-week levels, market capitalisation, revenue reference points and sector context. Univest also brings together Astrazeneca Pharma India Stock News, Astrazeneca Pharma India Share Price Today and Astrazeneca Pharma India Stock Analysis in one place so that the event can be reviewed alongside fundamentals and peer comparison.
For anyone following Astrazeneca Pharma India Share Price Live, Univest provides a practical way to monitor the one-year low, the current trading level and the company’s valuation profile without mixing the day’s move with unsupported conclusions. That is especially useful when Astrazeneca Pharma India Share Price is at a fresh 52-week low and the important question is how price action and financial metrics line up.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What happened to Astrazeneca Pharma India Share Price today?
Ans. Astrazeneca Pharma India Share Price fell 0.17% to Rs 6,020.3 and touched a fresh 52-week low of Rs 5,942.3 during morning trade. The previous close was Rs 6,030.45, and the market capitalisation stood at Rs 15,076.13 crore.
Why is Astrazeneca Pharma India Share Price in news?
Ans. Astrazeneca Pharma India Share Price is in news because it touched a fresh 52-week low in early trade. According to Univest data, the price event is confirmed, but no company-specific catalyst is established for the move.
What is the current Astrazeneca Pharma India Share Price?
Ans. Astrazeneca Pharma India Share Price last traded at Rs 6,020.3 as of 05 October 2026 at 9:22 AM IST. It moved between Rs 6,078.15 and Rs 5,942.3 in the session and remained below the previous close.
What is the fresh 52-week low for Astrazeneca Pharma India Share Price?
Ans. The fresh 52-week low for Astrazeneca Pharma India Share Price is Rs 5,942.3. The stock touched that level in the morning session, making it a yearly low event rather than an all-time low.
How does Astrazeneca Pharma India Share Price look on valuation?
Ans. Astrazeneca Pharma India Share Price trades at a P/E of 88.88 and a P/B of 16.67. Both are above the industry median, which places valuation at the center of any fundamental analysis of the stock.
What do ROE and ROCE show for Astrazeneca Pharma India Share Price?
Ans. Astrazeneca Pharma India Share Price shows ROE of 23.02% and ROCE of 31.24%. Those figures are above the industry median and industry average, which provides useful context for fundamental analysis and peer comparison.
How does Astrazeneca Pharma India Share Price compare with peers?
Ans. Astrazeneca Pharma India Share Price has a higher P/E and P/B than the listed peers in this comparison set, while its ROE and ROCE are also stronger than several of them. Its market capitalisation is broadly similar to the group.
What is the latest revenue reference for Astrazeneca Pharma India Share Price?
Ans. The latest revenue reference for Astrazeneca Pharma India Share Price is Rs 682.79 crore for Jun 2026. That figure gives a current operating context and is useful when reading valuation and market cap together.
Should investors track Astrazeneca Pharma India Share Price on Univest?
Ans. Yes, investors tracking Astrazeneca Pharma India Share Price can use Univest to follow live price, 52-week levels, valuation ratios and sector comparison in one place. That helps place the fresh low within a broader market update framework.
